In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals

被引:83
作者
Ikäheimo, I
Syrjälä, H
Karhukorpi, J
Schildt, R
Koskela, M
机构
[1] Oulu Univ Hosp, Clin Microbiol Lab, Oulu 90221, Finland
[2] Oulu Univ Hosp, Dept Infect Control, Oulu, Finland
[3] Univ Oulu, Dept Med Microbiol, Oulu, Finland
[4] Natl Vet & Food Res Inst, Helsinki, Finland
关键词
D O I
10.1093/jac/46.2.287
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The in vitro susceptibility of 38 strains of Francisella tularensis (biovar F. tularensis palaearctica) was determined using Etests on cysteine heart agar plates with 2% haemoglobin. All strains were susceptible to the antibiotics traditionally used to treat tularaemia, such as streptomycin (MIC90 4.0 mg/L), tetracycline (MIC90 0.38 mg/L) and chloramphenicol (MIC90 0.38 mg/L), and to aminoglycosides, such as tobramycin (MIC90 1.5 mg/L) and gentamicin (MIC90 1.0 mg/L). The quinolones examined had low MIC(90)s: ciprofloxacin, 0.016 mg/L; levofloxacin, 0.016 mg/L; grepafloxacin, 0.047 mg/L; and trovafloxacin, 0.032 mg/L. in contrast, all the strains were resistant to beta-lactams and azithromycin. Quinolones thus seem to be promising drugs for the treatment of tularaemia.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 10 条
[1]   ANTIMICROBIAL SUSCEPTIBILITY TESTING OF FRANCISELLA-TULARENSIS WITH A MODIFIED MUELLER-HINTON BROTH [J].
BAKER, CN ;
HOLLIS, DG ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (02) :212-215
[2]  
CROSS JT, 2000, PRINCIPLES PRACTICE, P2393
[3]   STREPTOMYCIN AND ALTERNATIVE AGENTS FOR THE TREATMENT OF TULAREMIA - REVIEW OF THE LITERATURE [J].
ENDERLIN, G ;
MORALES, L ;
JACOBS, RF ;
CROSS, JT .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (01) :42-47
[4]   TULAREMIA - A 30-YEAR EXPERIENCE WITH 88 CASES [J].
EVANS, ME ;
GREGORY, DW ;
SCHAFFNER, W ;
MCGEE, ZA .
MEDICINE, 1985, 64 (04) :251-269
[5]   DETECTION OF FRANCISELLA-TULARENSIS IN BLOOD BY POLYMERASE CHAIN-REACTION [J].
LONG, GW ;
OPRANDY, JJ ;
NARAYANAN, RB ;
FORTIER, AH ;
PORTER, KR ;
NACY, CA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (01) :152-154
[6]  
*NAT COMM CLIN LAB, 1998, M100S8 NCCLS
[7]   SUSCEPTIBILITY PATTERN OF SCANDINAVIAN FRANCISELLA-TULARENSIS ISOLATES WITH REGARD TO ORAL AND PARENTERAL ANTIMICROBIAL AGENTS [J].
SCHEEL, O ;
HOEL, T ;
SANDVIK, T ;
BERDAL, BP .
APMIS, 1993, 101 (01) :33-36
[8]  
Sjostedt A, 1997, J CLIN MICROBIOL, V35, P1045
[9]   INVITRO SUSCEPTIBILITY OF FRANCISELLA-TULARENSIS TO FLUOROQUINOLONES AND TREATMENT OF TULAREMIA WITH NORFLOXACIN AND CIPROFLOXACIN [J].
SYRJALA, H ;
SCHILDT, R ;
RAISAINEN, S .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (02) :68-70
[10]  
SYRJALA H, 1985, SCAND J INFECT DIS, V17, P371